Top Ten most popular articles on Pharmafile.com this week
November 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten
As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
GSK’s R&D head to move on after shift in focus
November 3, 2017Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
GSK’s experimental multiple myeloma scores Breakthrough designation with FDA
November 3, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
Teva’s woes continue, as shares sink to 17-year low on Q3 results
November 2, 2017Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
Tissue Regenix promotes new CEO from within
November 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix
Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
FDA issues warnings in crackdown on baseless cannabis miracle cures
November 2, 2017Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma
The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …
Sanofi Q3 results disappoint due to waning diabetes sales
November 2, 2017Sales and Marketing Lantus, Sanofi, diabetes, pharma
Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …
New test could determine womens’ risk of miscarriage or premature birth
November 2, 2017Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy
Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …
Allergan ready to take a loss by selling Teva shares
November 2, 2017Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …
Novartis reveals the data behind its showdown with Gilead
November 1, 2017Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical
Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …
Topas Therapeutics brings in new CMO
November 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical
Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …
CAR-T is bringing true precision to the fight against cancer
November 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Gilead, Kymriah, Novartis, Yescarta
Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …
Roche’s Tecentriq approved for funding in UK in bladder cancer
November 1, 2017Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical
In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …
Indivior’s opioid addiction treatment recommended by FDA advisory panel
November 1, 2017Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
CEO and President implicated as price-fixing probe widens
November 1, 2017Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical
A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
AstraZeneca asthma therapy tralokinumab flops at Phase 3
November 1, 2017Research and Development AstraZeneca, MedImmune, asthma, pharma
AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …
Cancer death rates 61% higher in poorer areas
November 1, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
Shire to streamline operations with 100-strong plant sale and in-house Cinryze production
October 31, 2017Manufacturing and Production, Sales and Marketing Cinryze, Shire, pharma
Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, having already entered active …
Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals
October 31, 2017Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia
LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
